Angiosarcoma

Three types of scalp angiosarcoma

Cutaneous angiosarcoma (4) CD31

Angiosarcoma is a rare and aggressive form of cancer that originates in the endothelial cells lining the blood vessels. This malignancy can occur in any part of the body but is most commonly found in the skin, breast, liver, and spleen. Due to its origin in the vascular system, angiosarcoma is known for its rapid growth and potential to metastasize, making early diagnosis and treatment crucial for patient outcomes.

Etiology and Risk Factors

The exact cause of angiosarcoma is not well understood, but several risk factors have been identified. These include:

• Radiation therapy: Exposure to radiation, often from previous cancer treatments, is a significant risk factor.
• Chronic lymphedema: A condition often associated with breast cancer surgery, where fluid accumulates in soft tissues, causing swelling.
• Chemical exposure: Certain chemicals, such as vinyl chloride and arsenic, have been linked to the development of angiosarcoma, particularly in the liver.
• Advanced age: Angiosarcoma incidence increases with age, typically affecting individuals over 70 years old.

Symptoms

Symptoms of angiosarcoma vary depending on the tumor's location but may include:

• Skin lesions that appear as purple or reddish nodules or spots.
• Swelling or a lump in the affected area.
• Pain or a feeling of heaviness in the affected area.
• For liver angiosarcomas, symptoms might include abdominal pain, weight loss, and jaundice.

Diagnosis

Diagnosing angiosarcoma involves a combination of clinical evaluation and diagnostic tools, including:

• Imaging tests such as CT scans, MRIs, and ultrasound to visualize the tumor.
• Biopsy of the tumor tissue to confirm the diagnosis through histological examination.
• Blood tests to assess overall health and liver function, especially in cases of suspected liver angiosarcoma.

Treatment

Treatment of angiosarcoma is challenging due to its aggressive nature and tendency to metastasize. Options include:

• Surgery to remove the tumor, often the first line of treatment if the cancer is localized.
• Radiation therapy as a post-surgical treatment or for palliative care.
• Chemotherapy and targeted therapy, although the effectiveness of these treatments can vary.
• Clinical trials, offering access to new and experimental treatments.

Prognosis

The prognosis for angiosarcoma patients is generally poor, with survival rates significantly lower than many other cancers. Factors affecting prognosis include the tumor's size, location, and whether it has metastasized. Early detection and treatment can improve outcomes, but the disease's aggressive nature often complicates this.

Prevention

There are no specific measures to prevent angiosarcoma. However, minimizing exposure to known risk factors, such as avoiding radiation exposure and chemical carcinogens, may reduce risk.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian